Heart and Blood Vessel Diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion: 1.Patient with 18 years of age. 2. Patient has signed and dated study informed consent. 3. Patient is able to receive pectoral implant. 4. Patient with pacemaker indication. 5. patient has left ventricular ejection fraction = 45%. 6. Patient will likely remain on a stable cardiac drug regimen, including antiarrhythmic agents throughout the 12 month follow-up period.
Exclusion criteria
Exclusion criteria: Exclusion: 1.Patient has mechanical right heart valve. 2. Patient is under the age of 18 or a minimum age as defined by local law. 3. Pastient has experienced unstable angina, acute myocardial infarction, CABG or PTCA within the past 3 months. 4. Patient with permanent atrial fibrillation. 5. Patient is enrolled in any concurrent study that would confound the results of this study. 6. Patient has a life expectancy of less than 6 months. 7. Women who are pregent, or with child-bearing potential and who are not on any form of birth control. 8. Patient has had a heart transplant.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Biventricular pacing is better than RVA pacing in preserving LV function in patients with standard indication for pacing.; | — |
Countries
China